Totally Share Discussion Threads

[hybrasil] 17/10/2022 14:35

Just gone through the RNS's since Bob Holt joined on the 25/8/15.

Total spend on Acquisitions since that date £51.9 million being Premier physical Healthcare (£6.75m)About Health (£7.7m) Optimum Sports Performance (£.65M) Vocare (£11m)
Greenbrook (£11.5m) Energy Fitness (£1.3M) and Pioneer Healthcare (£13m).

[microscope] 17/10/2022 14:01

Government are going to have to be squeaky clean from now on if they want to survive, and if they fail on that, Labour will replace them and inject vast amounts into the NHS .Very risky short I'd say, (unless the whole market crashes, in which case almost every stock is probably a short), but TLY is in a sector likely to be one of the very first to rebound.

[hybrasil] 17/10/2022 13:55

which is his mates company?

[mikeh30] 17/10/2022 13:21

Hunt ain't gonna help TLY. He'll divert anything possible into his mates company's or an American firm. Short to 20p

[sikhthetech] 14/10/2022 15:48

Jeremy Hunt is appointed new Chancellor.

From 2012 to 2018, Jeremy Hunt was the Health Secretary.
As Health Secretary he increased NHS spending and use of private companies.

Therefore, he is well aware of the problems facing the NHS and what actions need to be taken to address the long waiting times.

This is great news for TLY as there's likely to be increased focus on reducing NHS waiting times.

TLY provides it's services in all 4 UK nations and Republic of Ireland.

Increasing recurring revenues £127m
Cash £15m
Pays dividend

Mcap £57m

[hybrasil] 14/10/2022 07:45

Bob holt goes in as ceo of revolution beauty. Could he bring some of the products to our share price please!

[sikhthetech] 13/10/2022 15:17

NHS England waiting list continues to grow and now hits 7m.

TLY's outsourcing tackles the backlog of operations in all 4 UK countries and Republic of Ireland.


Fewer ops being done as NHS waiting list hits seven million

[andymunchkin] 13/10/2022 15:04

nigeldoug112 Jul '22 - 09:46 - 18954 of 19220
0 1 0
The only question is whether margins will rise or fall..
-----
weLL thePrice been colLaPsing pumpersBeen seLLigQuieTly 2op or 15p urGuess

[ammons] 08/10/2022 16:31

There are plenty of undervalued companies on the stockmarket right now. TLY do not stand out as particularly attractive. Mine are SQZ and HBR. TLY will stand out at 20p or less.

[sikhthetech] 07/10/2022 16:18

IC Alpha..

From Surprised on lse:

'...More must be done urgently to bust the patient backlog for NHS treatment. One way is to enlist more help from the private sector to reduce pressure on hospitals and help cut waiting lists. Purchasing private capacity is not new, the pandemic demanded unprecedented block-booking arrangements with private health care operators. However, given the staffing shortages across all sectors of the NHS, private health care companies are likely to play an even greater role in the future if the UK Government is going to service the public demand.

This is good news for one Aim-listed company that reduces reliance on the public sector through the delivery of efficient, responsive healthcare, ensuring access to high quality care for patients as well as wellbeing services in the workplace.

Despite being forecast to deliver in excess of 100 per cent earnings growth over the next two years, this company is tantalisingly priced on a 2023/24 forward PE ratio of just 10 times. The group is strategically aligned with NHS policy, specifically focused on the delivery of non-acute care components out of hospitals and closer to home. High demand isn’t going to change any time soon given record backlogs in the NHS and a buy-and-build strategy has created the infrastructure to deliver a range of services. For good measure, the business is cash generative and has a cash rich balance sheet to deploy on further earnings accretive acquisitions

1. Strong organic growth underpins a positive earnings cycle.
2. Raft of NHS contract extensions and new awards.
3. Recent acquisitions materially de-risk earnings growth forecasts.
4. Increased insourcing capacity is a game changer.
5. Huge opportunity to grow elective care and outsourcing services.
6. £36bn NHS package to tackle Covid-19-induced backlog and waiting lists.
7. NHS pays for services in advance to eliminate bad debt risk.
8. Cash-generative.
9. Cash-rich balance sheet supports further earnings-accretive acquisitions.
10. Potential bid target.

A total package for profitable growth

Totally is strategically aligned with NHS policy: specifically, the group is focused on the delivery
of non-acute care components out of hospitals and closer to home, and trends towards
outsourcing and outcome-based commissioning. The approach is underpinned by five strategic
pillars:
? Delivering core market growth.
? Securing market share gains as the partner of choice.
? Driving synergies across a growing business.
? Building strong long-term strategic and operational relationships.
? Identifying opportunities to grow both organically and through acquisition.

There are decent prospects of the group delivering bumper organic growth in the coming
years. The business should be buoyed by ongoing demand from the NHS, upside from previous acquisitions, and by deploying the £15.3mn (8p a share) net cash pile to make further complementary earnings accretive bolt-on acquisiaccretive bolt-on acquisitions.....Allenby expects the group to more than double pre-tax profit and earnings per share (EPS) to £7.9mn and 4.16p, respectively, in the two years to 31 March 2024 based on revenue rising from £127.4mn to £160mn. The predictions look well underpinned by the fundamentals driving demand for the group’s services, and suggest that the shares – priced on modest forward price/earnings ratios of 14 (2022/23) and 10 (2023/24) – offer material potential for a
re-rating. Moreover, a closer look at each operating division suggests that there could even be upside to these bumper earnings estimates.............................Target price 70p'

[doobz] 07/10/2022 10:12

Any ideas on today's strength? Tipped?

[thordon] 06/10/2022 23:01

Go to bed imastu pidgitaswell you have been found out

As for a note from post in past

"It appears to me that the largest segment of liabilities comes from upfront payment of services not yet rendered and outstanding amounts on acquisitions ."

Nothing new. That has been their strategy since Bob Holt joined some 6yrs ago. They have continued their stated strategy.

Using that strategy they have significantly grown the business so now it is a diversified business model, covering Urgent Care, Planned Care, Insourcing, Organisation wellbeing and operating in all 4 UK nations plus Republic of Ireland and paying dividends.

Last 5 years:
period revenue, cash, adj Ebitda
2017 £21.3m, £11.3m, £5.6m
2018 £42m, £10.2m, £0.2m
2019 £78m, £7.5m, £1.1m
2020 £105m, £8.9m, £4m
2021 £113m, £14.8m, £5m
2022 £127.4m, £15.3m, £6.2m

Mcap £57m


Cash flow is king in a expanding company , now go back to your hiding where you are truly invested in ; but that's the point as your own shares have taken a battering and blame sikhthetech when in truth is the facts.

Will have to say i'm not one for revenge but this is our platform on shares which is not yours.

Did look at your investments and well you get what you do not research well.

[imastu pidgitaswell] 06/10/2022 21:47

"there are selected holes in your statement , which have been brought up time and time again and dealt with"

But they haven't, have they?

Where did anyone address the specifics and quantification that I noted above - never mind 'time and time again'? Go back and read the discussion around the time of the results release, and since.

There is nothing about the net current liabilities, the cash commitments on the balance sheet, the temporary working capital enhancement of the cashflow statement and most of all absolutely nothing about the accruals and deferred income balances set up for the acquisitions, which will hide the cash payments as they are made.

Always the same - specific, quantitative issues are ignored or brushed over; sweeping statements about strategy and 'the NHS' are quickly deployed instead. It's your funeral.



Edit - not going to continue this pitiful exchange, but in response to your follow-up (there is no comment about the specifics - dragging up a qualitative statement from 2019 isn't a response) and false personal jibes - ask sikh about TW. and selling them all in 2021 and six figure profits - the full table you just posted should read (acquisitions cost money and shareholders funds):

Period.....revenue..........cash.......ebitda......Profit After Tax........EPS
2019......... £78m........ £7.5m........£1.1m..........(£1.5m) ..........(2.51)p
2020.........£105m.........£8.9m,.........£4m..........(£2.8m)...........(1.82)p
2021.........£113m........£14.8m..........£5m...........£0.3m.............0.17p
2022.......£127.4m........£15.3m........£6.2m...........£1.1m.............0.58p

So just the 55 times earnings, down from 80-odd. The strategy is very clear - it may or may not work - but the information that flows from it that is posted on here is very selective, omits the most important parts, and glosses over fundamental issues of cash generation and use. Quantified specifics, not qualitative statements.

[thordon] 06/10/2022 20:34

Lol good luck ammons

[ammons] 06/10/2022 19:24

I am lowering my buy price to 20p.

[sikhthetech] 06/10/2022 19:08

Thordon,

This was explained to 1gw some time ago but he failed to understand the simple concept. So his mates keep coming back with the same BS.

TLY's strategy is to buy companies by paying some up front and the remaining as deferred performance based payments.
I don't have a problem with the strategy as it has worked really well.



sikhthetech - 20 Oct 2019 - 20:53:58 - 10821 of 19213 Totally Health
1gw,

The company has been following their stated strategy of 'Adding and Building', as expected..

They have now set the foundation and are NOW growing, fy revenues expected to be £100m+++, expected to pay dividends, not expecting cashflow issues...

You've been proven wrong so many times... there's no 'horrific' balance sheet, Chairman and CEO are still there, Harrisons sold and still the business is doing well...


The fact is that against the backdrop of political uncertainty, they have won a NEW contract, extended existing contracts, have intention to pay a dividend... shows the BoD don't have concerns over cash flow...

The fact is that despite you claiming the CFO would agree with you that their balance sheet is 'horrific', Lisa has never stated nor implied it...


A £100m++ revenue producing, dividend paying company...All for a MCAP of only £21m...

[thordon] 04/10/2022 20:49

Do lol imastu pidgitaswell as looking back on your post its very clear that Sikhthetech is your no1 fan
So please stick to your own shares and try and restrain involving your sulks and bitterness on this forum.
As for Totally there are selected holes in your statement , which have been brought up time and time again and dealt with.

[imastu pidgitaswell] 03/10/2022 21:53

19208 - that's acquisition accounting for you (and see below).

Don't forget the £6.6m of contingent consideration sitting as a liability on the balance sheet - cash out of the door, very soon (not to mention the £6m+ out of the door in the year just ended). £14.1m acquisition cost, for £2.2m of tangible assets for the largest one, Pioneer. Hmmmm...

Also note the cashflow statement, flattered by working capital movements in both years - the underlying operating cashflow numbers being c£6m, not £11m and £9m for the past 2 years - those cashflows being before payments for acquisitions, tax, fixed assets and lease liabilities...

Negative net current assets (including their much-trumpeted £15m cash) of some £14m - due to the accruals and deferred income and the deferred cash consideration. This is the well hidden time-bomb (their full financial statements reveal it - not the summary version that is the RNS); they have recorded all sorts of costs from the businesses they have acquired as a cost of acquisition (thereby avoiding recording them as operating costs) and when they come to pay these costs, in cash, they will reduce this accruals balance and reduce the cash - both balance sheet items. So the reported earnings will apparently be OK, but the cash will be flying out of the door. Classic acquisitions accounting trickery - legal but frankly misleading. Some might say...

And don't mention the negative £14m net tangible assets. Please don't.

Just the 55 times earnings, in this market, with a business that faces "the same challenging operating environment as the NHS and other businesses in relation to staffing, recruitment and increasing costs" - wot could possibly go wrong? 😳

[johndoe23] 03/10/2022 11:41

Sitting right on historic support, which way it'll go could be anyone's guess...

[mikeh30] 01/10/2022 16:57

"The goodwill is attributable to the knowledge and expertise of the workforce" 11 million quids worth?

[mikeh30] 30/9/2022 20:50

Stinks this one does. Massive mark up on the intangible assets to fluff the statements.Trade payables up massively and a magic £11 MILLION has popped up forGoodwill. Big 'ol red flags a plenty

[owenski] 30/9/2022 16:53

Not really an attractive stock or business model is it.

[slopsjon2] 30/9/2022 15:55

The AIM all share is down 39% since this time last year, 33% YTD.

[legaleagle66] 30/9/2022 15:21

The direction of travel looking one way..downward it appears.?